Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy

NCT07006493 is registered in ClinicalTrials.gov with SuZhou Sinus Medical Technologies Co.,Ltd as lead sponsor.

NCT NCT07006493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07006493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy
Lead sponsor
SuZhou Sinus Medical Technologies Co.,Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
July 20, 2025
Completion date
December 30, 2027
Enrollment
124 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy, obstructive